Prof. Angela Morgan is an NHMRC Practitioner Fellow and leads the Speech and Language group at the Murdoch Children's Research Institute. She is also Professor of Speech Pathology at the University of Melbourne.
Angela has over 20 years of clinical-research experience. Her career has been focused on better understanding predictors, prognostic factors and causation for childhood speech and language disorders. Her early career focused on these challenges in children with acquired brain injury, including in children with traumatic brain injury, stroke and brain tumour.In recent times, Angela's research focus has turned to better understanding biological causation for these conditions. Angela currently leads the NHMRC CRE in Speech and Language which focuses on: (i) identification of new gene pathways leading to child speech and language disorders, (ii) conducting genotype- speech phenotype studies for rare genetic syndromes leading to more targeted therapies, and (iii) elucidating the neurobiology of genetic-based speech and language disorders using quantitative brain imaging techniques. Angela and team have identified over 50% of known single genes for a debilitating speech disorder, known as childhood apraxia of speech. Her team have also characterised speech and language in children with a number of known genetic syndromes, single gene and copy number variant conditions, including: FOXP2-related speech and language disorders, Kabuki syndrome, Floating Harbor Syndrome, 16p11.2 deletion, Koolen de Vries Syndrome, GRIN2A-related speech disorder, Dravet Syndrome, Beckwith Weidemann Syndrome and Klinefelter Syndrome. As a result of her expertise in speech outcomes in these children, Angela is increasingly leading trials, or consulting on speech outcome measures for pharmacological trials in children with rare genetic conditions. At a population level, Angela leads the phenotyping arm of a large genome wide association study examining biological contributions to stuttering.Angela's research is published in well-respected cross-disciplinary journals including the British Medical Journal, Brain, Neurology, Molecular Psychiatry and Neuroscience and Biobehavioural Reviews. She also publishes in discipline specific journals to ensure her translational clinical work reaches the appropriate audience. She has also led development of a number of clinical guidelines including the NHMRC endorsed guideline for management of speech, language and swallowing in children with traumatic brain injury and the NIH affiliated Gene Review on FOXP2-related speech and language disorder.
Find out more about Angela Morgan's experience
Angela Morgan's highlights
FEATURED Journal article
The neural basis of nonword repetition in children with developmental speech or language disorder: An fMRI study
Read moreAngela Morgan's selected work
Projects
Displaying the 2 most recent projects by Angela Morgan.
Project Types
1
Research Contracts
1
Research Grant
Scholarly Works
Displaying the 163 most recent scholarly works by Angela Morgan.
Keyword Analysis
News
Displaying the most recent news article by Angela Morgan.
Honours, Awards and Fellowships
Victorian Young Tall Poppy Award
National Health and Medical Research Council Achievement Award
Australian Postgraduate Award
Speech Pathology Australia
University of Queensland Medal
Harold Mitchell International Travelling Fellowship
Dean of Medical Faculty award
Undergraduate Scholarship
Credentials
Positions
Research And Teaching - Speech Pathology
Audiology And Speech Pathology
Education
Speech Pathology
The University of Queensland
Speech Pathology
The University of Queensland